Reported Jan 6, 2021 · Terminated

Esomeprazole Magnesium for Delayed-Release Oral Suspension 20mg, packaged in unit dose packets, Rx only, Manufactured…

Cipla

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: CIPLA · 10 Independence Blvd · Warren, NJ · 07059-2730

Is this the product you have?

  • Esomeprazole Magnesium for Delayed-Release Oral Suspension 20mg, packaged in unit dose packets, Rx only
  • Manufactured byCipla Ltd., Kurkumbh, India
  • Manufactured for
    • Cipla USA
    • Inc. 10 Independence Boulevard
    • Suite 300 Warren
    • NJ 07059
    • NDC 69097-528-34
Lot codes and dates
    • Lot #: KA00413
    • KA00414
    • KA00461
    • Exp 11/2021
Amount recalled
289350 packets

This recall covers 3 products

The agency filed one notice per product. You are reading one of them; the other 2 are below.

Where it was sold

  • Nationwide

Why it was recalled

Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Cipla recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Dec 7, 2022 · Data as of Sep 19, 6:38 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.